The Handover is a medical newsletter and website that distills the latest research, guidelines, and career topics into concise, engaging summaries for busy clinicians and medical students. It prioritizes editorial clarity and a wry tone, making complex studies like the MERCURI-2 trial accessible in five-minute reads. The platform also serves as a searchable archive of its weekly issues.
Funding
Funding not disclosed
Founders
Product
Problem
Medical professionals are overwhelmed by a constant flood of research, guidelines, and industry news, much of which is too dense, dry, or shallow to be useful at a glance. This information overload makes it difficult for clinicians to stay current with practice-changing evidence and career-relevant updates without dedicating significant time to reading journals and tracking sources.
Solution
The Handover filters and distills the most important medical stories into concise, engaging summaries that are both medically literate and editorially honest. It focuses on four key areas—research, innovation, deep dives, and career issues—to provide fast updates, larger explainers, and human-interest stories. The platform combines a weekly newsletter with a searchable website archive, offering a better reading experience and a permanent home for its content. The tone is designed to be clear, witty, and relatable, ensuring that staying informed does not feel like homework.
Target Audience
The primary audience is UK-based doctors and medical students who want to stay current with medical research and career topics without sifting through dense journals or endless LinkedIn debates.
Features
- Concise, five-minute summaries of landmark trials and guidelines, such as the MERCURI-2 and COBRRA trials.
- A searchable website archive with readable article pages and issue-specific archives for the current era.
- Four content lanes: research, innovation, deep dives, and breaking the bottleneck, covering everything from drug comparisons to career policy.
- A weekly newsletter with a free-forever model, delivering the latest updates directly to subscribers' inboxes.
- Editorial approach that includes critical analysis, such as highlighting funding biases in trials and contextualizing statistical significance with absolute risk reductions.